Melanotan II vs Octreotide
Overview
Melanotan II is primarily a cosmetic & skin peptide, while Octreotide is used for hormonal.
This page compares Melanotan II and Octreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Melanotan II | Octreotide | |
|---|---|---|
| Category | Cosmetic & Skin | Hormonal |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 250-500 mcg | 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) |
| Frequency | as needed | Every 4 weeks (LAR); two to four times daily (immediate-release) |
| Reported benefits | Skin tanning without UV exposure, increased libido, potential appetite suppression | Reduction of growth hormone and IGF-1 in acromegaly, suppression of carcinoid flushing and diarrhea, control of VIPoma-associated watery diarrhea, antiproliferative effect on low-grade neuroendocrine tumors, reduction of urinary 5-HIAA biomarkers |
| Reported side effects | Nausea, facial flushing, darkening of moles, potential cardiovascular effects | Gallstones and biliary sludge, diarrhea, nausea, abdominal discomfort, sinus bradycardia, hyperglycemia, hypoglycemia, hypothyroidism, steatorrhea, injection-site pain |
Key differences
Primary use. Melanotan II is categorised under Cosmetic & Skin, while Octreotide falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Melanotan II: not FDA-approved; compounding permitted with a prescription as of April 2026. Octreotide: FDA-approved.
Dosing. Melanotan II is typically dosed at 250-500 mcg (as needed). Octreotide is typically dosed at 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) (Every 4 weeks (LAR); two to four times daily (immediate-release)).
Can you stack them?
Some protocols combine peptides, but stacking Melanotan II and Octreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Melanotan II and Octreotide?
- Melanotan II is primarily a cosmetic & skin peptide, while Octreotide is used for hormonal. Melanotan II is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Octreotide is FDA-approved for one or more indications.
- What is Melanotan II used for?
- Tanning, libido.
- What is Octreotide used for?
- FDA-approved somatostatin analog for acromegaly, carcinoid syndrome, and VIPomas since 1988.
- Can you take Melanotan II and Octreotide together?
- Some users combine peptides within a single protocol, but stacking Melanotan II and Octreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Melanotan II or Octreotide FDA-approved?
- Melanotan II is not FDA-approved; compounding permitted with a prescription (as of April 2026). Octreotide is FDA-approved for one or more indications.
Read the full articles
- Melanotan II — full monograph: mechanism, research, dosing & references
- Octreotide — full monograph: mechanism, research, dosing & references